CUC Inc.

Research CUC Inc. (9158.T) on Bullrun: market cap JPY 20.90B, P/E 8.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is JPY 20.90B; P/E is 8.8.

Peer valuation comparison

Latest P/E is 8.84x versus a Healthcare sector median of 21.69x (59.2% below).

Latest P/E is 8.84x versus a Japan median of 14.28x (38.1% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026JPY 54.35BJPY 2.85B-JPY 1.03B46.8%n/aJPY 15.84BJPY 52.53BJPY 33.25B
FY2025JPY 47.04BJPY 3.13B-JPY 3.08B49.3%106.81JPY 7.53BJPY 43.54BJPY 29.68B
FY2024JPY 33.03BJPY 2.60B-JPY 747.00M48.2%93.99JPY 8.26BJPY 26.72BJPY 27.32B
FY2023JPY 35.21BJPY 2.42B-JPY 3.23B39.1%113.91JPY 4.12BJPY 21.45BJPY 11.70B
FY2022n/an/an/an/a129.71n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18JPY 20.90B8.8n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 JPY.

About CUC Inc.

CUC Inc. offers healthcare services in Japan and internationally. It provides medical institution operations support, including strategic, administrative, marketing, HR/recruiting, and procurement support, as well as support for IT, accounting, general affairs, etc.; medical institution revenue growth assistance services, such as M and A, post-merger integration, hospital bed conversion, and clinic launches; and medical institution cost optimization support.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is CUC Inc.'s market cap?

CUC Inc.'s market capitalization is JPY 20.90B.

What is CUC Inc.'s P/E ratio?

CUC Inc.'s price-to-earnings (P/E) ratio is 8.8.

What does CUC Inc. do?

CUC Inc. offers healthcare services in Japan and internationally. It provides medical institution operations support, including strategic, administrative, marketing, HR/recruiting, and procurement support, as well as support for IT, accounting, general affairs, etc.; medical institution revenue growth assistance services, such as M and A, post-merger integration, hospital bed conversion, and clinic launches; and medical institution cost optimization support.